DIABEgen

Precision medicine for type 2 diabetes

Patia presents diabegen™, a genomic tool that analyzes the main genetic variants associated with type 2 diabetes and offers the physician individualized considerations for a precise intervention in the management of the disease.

In recent years, multiple scientific publications have described genotype/phenotype associations in the development of type 2 diabetes and its complications.

Patia has selected genetic variants associated with certain glycemic features and clinical implications, to provide relevant information for the management of type 2 diabetes

Genomics for intervention

Type 2 diabetes is a complex disease, for which direct and indirect genotype-phenotype associations have been identified: genotype/symptomatology of the disease, genotype/cellular functions

A sample of the patient’s DNA provides useful information for matching treatment to the patient’s medical history and other complementary tests.

Scientific reliability

diabegen™ has been developed in collaboration with scientists and endocrinologists at The Broad Institute of MIT and Harvard, (Cambridge, USA) and The Massachusetts General Hospital (Boston, USA):

• Sci Rep 2019, 9(1):2748.
• Nature 2014, 506(7486):97-101.
• JAMA 2014,311(22):2305-2314.
• Nat Genet. 2014, 46(3):234-244.
• Nat Genet. 2012, 44(9):981-990.
• PLoS Genet. 2015,11(12):e1005696.

Genotype information, along with clinical criteria, is a powerful tool in the hands of the physician for the management of the patient diagnosed with type 2 diabetes or pre-diabetes”

Mirella G. Zulueta, MD, PhD Patia’s Medical Director

Recommendations informed by genotype

The results report provides relevant information for the physician on lifestyle (with specific suggestions for nutrition and physical exercise), supplements, pharmacological indications and other clinical tests to be assessed in the patient’s entire medical history.

Nutrition

Optimal nutrients to be included in the patient’s eating habits and others to be excluded from their diet

diabegen™  identifies genetic polymorphisms to enable genotype-informed personalization of patient’s diet.

Physical activity

Specific indications of recommended exercise type according to genotype (aerobic or anaerobic). With diabegen™ the identification of polymorphisms associated with the impact of physical activity on glycemic homeostasis facilitates the personalization of the appropriate physical exercise.

Supplements

Food supplements containing minerals and vitamins suitable for intervention. diabegen™ identifies which dietary supplements may be beneficial to complement patient’s diet.

Pharmacology and Other medical test

The identification with diabegen™ of several genetic polymorphisms associated with response to different drugs facilitates the selection of the most precise drug treatment. Indication of the patient’s suitability and response to certain treatments and suggested complementary laboratory tests.

Clinical indication :

Individual diagnosed with DT2, pre-diabetes or high glycemia

Sampling :

Buccal epithelial cells (swab) or blood (EDTA tube)

Results available in:

12 business  days

I am a healthcare professional and I want to know more about DIABEgen.